NCT04959760View on ClinicalTrials.gov

BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test

NACompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

June 3, 2021

Primary Completion Date

January 20, 2022

Study Completion Date

January 20, 2022

Conditions
COVID-19 Respiratory Infection
Interventions
DIAGNOSTIC_TEST

The BinaxNOW™ Antibody Tests measure IgG antibodies against SARS-CoV-2.

The BinaxNOW™ Antibody Tests measure IgG antibodies against SARS-CoV-2 in fingestick capillary blood and plasma samples.

Trial Locations (5)

27705

Duke University Health System, Durham

29611

Urgent Care Clinical Trials, Powdersville

37209

Urgent Care Clinical Trials at Complete Health Partners, Nashville

60612

Rush University Medical Center, Chicago

75204

Urgent Care Clinical Trials, Dallas

All Listed Sponsors
lead

Abbott Rapid Diagnostics Jena GmbH

INDUSTRY